Study of a new version of a breast cancer drug in healthy volunteers
This trial tests a new version of a medication used for breast cancer. Because healthy people are needed first, it checks how the body processes the new drug and whether it causes side effects, helping to ensure it is safe before patients use it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male between 18 and 45 years old.
- Your weight is between 50 and 75 kg (110–165 lbs).
- Your body mass index (BMI) is between 19 and 24.
- You have no major health problems and your heart function is normal (LVEF ≥55%).
- You have not taken any prescription, over-the-counter, or herbal medicine in the last 28 days.
- You have not donated blood or lost more than 450 mL of blood in the last 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests two similar medicines, HLX29 and HLX11, in healthy men to see how the body absorbs and clears them and whether they are safe. Participation helps find out if one medicine can replace the other.
This trial tests a new medication (HLX319) against an approved treatment (Phesgo) given before surgery for HER2-positive breast cancer. The goal is to see if the new drug works just as well and is safe, potentially offering another option to help shrink tumors before surgery.
This trial tests a new drug (HLX43) for people with a certain type of advanced breast cancer that has stopped responding to hormone therapy. The goal is to see if the drug can shrink tumors or slow the cancer's growth.
This study tests a new pill called HLX97 for people with advanced breast, prostate, or lung cancer that has not responded to standard treatments. The goal is to find the safest dose and see if it can help slow or shrink the tumor.
This trial tests an investigational drug (HLX48) in people with advanced or metastatic solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how well it works.
This trial tests a new medication, HLX51, which may help the immune system fight cancer. It is for people with advanced solid tumors or lymphoma who have tried standard treatments without success or cannot receive them.
Hear when a new Health Adult Subjects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.